News

Atomic-level mapping of amorphous diabetes drug reveals hydrogen bonds as key to stability
Scientists at EPFL and AstraZeneca have developed a method to map the atomic-level structure of amorphous drugs, demonstrated ...
Altimmune outlines phase 3 pemvidutide plans and expands to alcohol-related liver indications while extending cash runway
Altimmune's Q1 2025 earnings call highlights breakthroughs in NASH treatments, robust financials with a new $100M credit facility, and imminent Phase ...